volume, recent price appreciation, pending listing on the London stock exchange would seem you're a little off the mark on this one
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025